This company has been marked as potentially delisted and may not be actively trading.

Forte Biosciences (FBRX) Stock Forecast & Price Target

Get the Latest News and Ratings for FBRX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Forte Biosciences and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FBRX Analyst Ratings Over Time

Type	Current Forecast 10/4/25 to 10/4/26	1 Month Ago 9/4/25 to 9/4/26	3 Months Ago 7/6/25 to 7/6/26	1 Year Ago 10/4/24 to 10/4/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$71.67	$71.67	$67.00	$68.00
Forecasted Upside	-6.91% Downside	-6.91% Downside	228.27% Upside	338.99% Upside
Consensus Rating	Hold	Hold	Moderate Buy	Moderate Buy

FBRX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

FBRX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Forte Biosciences Stock vs. The Competition

Type	Forte Biosciences	Healthcare Companies	Broader Market
Consensus Rating Score	2.00	2.31	2.53
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	-6.91% Downside	827.17% Upside	21.53% Upside
News Sentiment Rating	Neutral News See Recent FBRX News	Neutral News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
8/14/2026	Weiss Ratings 3 of 5 stars		Upgrade	Sell (E+) ➝ Sell (D-)
7/28/2026	Barclays 3 of 5 stars	Etzer Darout 5 of 5 stars	Downgrade	Overweight ➝ Equal Weight	$74.00 ➝ $77.00	+0.65%
7/27/2026	Evercore 3 of 5 stars		Set Target		$77.00	+0.73%
7/27/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
7/27/2026	Brookline Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
11/17/2025	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$61.00	+333.24%
8/18/2025	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yatin Suneja Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$75.00	+548.23%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 03:38 AM ET.

FBRX Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Forte Biosciences is $71.67, with a high forecast of $77.00 and a low forecast of $61.00.

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Forte Biosciences in the last twelve months. There is currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" FBRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FBRX, but not buy additional shares or sell existing shares.

According to analysts, Forte Biosciences's stock has a predicted downside of -6.91% based on their 12-month stock forecasts.

Over the previous 90 days, Forte Biosciences's stock had 5 downgrades and 1 upgrade by analysts.

Forte Biosciences has been rated by research analysts at Barclays, Brookline Capital Markets, Evercore, TD Cowen, and Weiss Ratings in the past 90 days.

Analysts like Forte Biosciences less than other "healthcare" companies. The consensus rating score for Forte Biosciences is 2.00 while the average consensus rating score for "healthcare" companies is 2.31. Learn more on how FBRX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Forte Biosciences Recommendations

MarketBeat monitors more than a dozen sources for Forte Biosciences analyst ratings, with the most recent rating issued on 8/14/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.